Rahul Amte

Rahul Amte

Auto-generated profile, based on publicly available information

Rahul Amte

Critical Care Division, Integrated Hospital Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2023 in Critical Care Research and Practice
Verified
Journal Article
Open access
PDF file
SYSangeeta Yelle
Sangeeta Yelle
RARahul Amte
Rahul Amte
VGVishwanath Gella
Vishwanath Gella
SMSasikala Mitnala
Sasikala Mitnala
DGDeepika Gujjarlapudi
Deepika Gujjarlapudi
NDNageshwar Reddy Duvvur
Nageshwar Reddy Duvvur
Background. Though vaccines have been reported as highly efficacious in preventing severe COVID‐19 disease, there is emerging data of severe infections, albeit a small number, in vaccinated individuals. We have conducted a retrospective observational study to assess the clinical characteristics, immunological response, and disease outcomes among the vaccinated and unvaccinated patients admitted to the ICU with severe COVID‐19 disease. Methods. Study Design and Participants. We conducted a retrospective observational study in COVID ICU of a tertiary care hospital. Data were collected from the month of 1 April 2021 to 31 November 2021. All adult patients admitted to the ICU having severe COVID‐19 disease were included in the study. Data were collected from the medical records database which included demographics, a clinical course in the ICU, laboratory and radiological parameters, and disease outcomes. In a subset of patients, cell‐mediated immunity and S1S2‐neutralising antibody assessment was done. Results. A total of 419 patients with severe COVID‐19 were included in the study. Of the 419 patients, 90 (21.5%) were vaccinated, and 329 (78.5%) were unvaccinated. There was a significantly higher mortality in unvaccinated severe COVID 19 patients as compared to vaccinated severe COVID patients (46.2% vs 34.4%; P < 0.0455). The neutralizing antibody titre was significantly higher in survivors as compared to nonsurvivors (2139.8, SE ± 713.3 vs 471, SE ± 154.4); P < 0.026. Conclusion. Our study suggests the association of lower neutralizing antibody levels with mortality in ICU patients admitted with COVID‐19 breakthrough infections.

29 September 2026 in Journal of Intensive Medicine
Verified
Journal Article
Open access
MTMona Tareen
Mona Tareen
JKJamshed Khan
Jamshed Khan
MAMoza Alzaabi
Moza Alzaabi
MIMariam Ibrahim
Mariam Ibrahim
DGDana Gefe
Dana Gefe
Jihad MallatJihad Mallat
Jihad Mallat

19 February 2026 in Journal of Intensive Medicine
Verified
Journal Article
Open access
Jihad MallatJihad Mallat
Jihad Mallat
NSNicolas Storme
Nicolas Storme
MAMohamed Askalany
Mohamed Askalany
MHMohamed Helal
Mohamed Helal
MDMehraj ud din
Mehraj ud din
OAOsama Abou-Arab
Osama Abou-Arab
The airway occlusion pressure (P0.1) reflects the central respiratory drive and correlates with patients’ inspiratory effort. This study aimed to assess whether changes in P0.1 (ΔP0.1) during the spontaneous breathing trial (SBT), as well as SBT-induced changes in the products of P0.1 and the rapid shallow breathing index (RSBI) (Δ(P0.1 × RSBI)) and P0.1 and respiratory rate ((Δ(P0.1 × RR)), can predict extubation failure (EF) in critically ill patients. In this bicentric prospective study, we enrolled 114 intensive care unit (ICU) patients who had been mechanically ventilated for more than 48 h and successfully tolerated a 30-min SBT on pressure support ventilation. Respiratory variables, including P0.1 and RSBI, as well as hemodynamic parameters, were recorded within 5 min of SBT initiation and at its completion. EF was defined as the need for reintubation and resumption of mechanical ventilation within 7 days. Areas under the receiver operating characteristic curves (AUCs) were calculated for both relative and absolute ΔP0.1, Δ(P0.1×RSBI), and Δ(P0.1×RR). Among the 114 patients, 23 (20.2%) experienced EF. At baseline, P0.1, P0.1×RR, and P0.1×RSBI values did not differ significantly between the success and failure groups. During the SBT, P0.1, P0.1×RR, and P0.1 × RSBI increased significantly in the failure group, while remaining unchanged in the success group. Absolute ΔP0.1 demonstrated poor predictive performance for EF, with AUC of 0.69 (P=0.005). In contrast, absolute Δ(P0.1×RSBI), and absolute Δ(P0.1 × RR) showed moderate predictive ability, with AUCs of 0.79 (P<0.001) and 0.76 (P<0.001), respectively. In the multivariable logistic regression analyses, the absolute, but not the relative, ΔP0.1, Δ(P0.1×RR), and Δ(P0.1×RSBI) remained independently associated with EF after adjustment for potential confounders. Variations in P0.1 and in the combined parameters P0.1×RSBI and P0.1×RR during the SBT provided limited value for predicting EF in critically ill patients. ClinicalTrials.gov, NCT05802745.